Publication Beamlines Strategic Pillar
Joan Seoane Suarez; Judit Anido Folgueira; Johan Fransson; Monica PASCUAL GARCIA; Ester BONFILL TEIXIDOR et al. (2021). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: EP3774895A1.
Joan Seoane Suarez; Judit Anido Folgueira; Johan Fransson; Robin Matthew Hallett; Monica PASCUAL GARCIA et al. (2019). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: CA3096779A1.
Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Johan Fransson; Robin Matthew Hallett; Monica PASCUAL GARCIA et al. (2021). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: US20210130453A1.
Joan Seoane Suarez; Judit Anido Folgueira; Patricia Anne GIBLIN; Peter Edward BAYLISS; Johan Fransson et al. (2021). Methods of quantifying lif and uses thereof. Patent Number: EP3806960A1.
Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Peter Edward BAYLISS; Patricia Anne GIBLIN; Johan Fransson et al. (2021). Methods of quantifying lif and uses thereof. Patent Number: US20210190798A1.
Joan Seoane Suarez; Judit Anido Folgueira; Robin Matthew Hallett; Patricia Anne Giblin; Jeanne Magram et al. (2019). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: CA3103369A1.
Joan Seoane Suarez; Judit Anido Folgueira; Robin Matthew HALLETT; Patricia Anne GIBLIN; Jeanne Magram et al. (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: EP3806899A2.
Joan Seoane Suarez; Judit Anido Folgueira; Robin Matthew HALLETT; Patricia Anne GIBLIN; Jeanne Magram et al. (2019). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: WO2019243900A2.
Joan Seoane Suarez; Judit Anido Folgueira; Robin Matthew HALLETT; Peter Edward BAYLISS; Ajitha JEGANATHAN et al. (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: EP3807315A2.
John Hayes (2016). Analysis of nuclear fuel cycle materials by X-ray absorption spectroscopy. Supervisor: Andrew Grosvenor. SK, CA: University of Saskatchwan. https://ecommons.usask.ca/handle/10388/ETD-2016-01-2382. CLS-APS, HXMA, SXRMB, VESPERS
John Hayes (2016). Analysis of nuclear fuel cycle materials by X-ray absorption spectroscopy. Supervisor: Andrew Grosvenor. SK, CA: University of Saskatchwan. https://ecommons.usask.ca/handle/10388/ETD-2016-01-2382. CLS-APS, HXMA, SXRMB, VESPERS
John Hayes (2016). Analysis of nuclear fuel cycle materials by X-ray absorption spectroscopy. Supervisor: Andrew Grosvenor. SK, CA: University of Saskatchwan. https://ecommons.usask.ca/handle/10388/ETD-2016-01-2382. CLS-APS, HXMA, SXRMB, VESPERS
John Hayes (2016). Analysis of nuclear fuel cycle materials by X-ray absorption spectroscopy. Supervisor: Andrew Grosvenor. SK, CA: University of Saskatchwan. https://ecommons.usask.ca/handle/10388/ETD-2016-01-2382. CLS-APS, HXMA, SXRMB, VESPERS
John Lippincott; Kelsey Sivick Gauthier; Nigel Pelham Clinton Walker; Xiaoning Zhao (2023). ANTIBODIES FOR TIGIT.. Patent Number: MX2022015157A.
John Robert Porter; Alastair Lawson; Daniel John Lightwood; Rebecca Jayne Wootton; James Philip O'connell et al. (2018). Antibody. Patent Number: CL2017003246A1.